Recent Research Funding

Carla Frederick, MD, with a patient in a clinical trial.

Carla A. Frederick, MD, conducts research with patients in international clinical trials. Gilead Sciences Inc., the Cystic Fibrosis Foundation and others have provided funding.

Research by members of our division is strongly supported by extramural and intramural funding.

We are backed by competitively awarded funding from sources including:

  • National Institutes of Health
  • U.S. Department of Veterans Affairs
  • New York state 

Our fellows have received prestigious awards, including the American Academy of Sleep Medicine Physician Sleep Scientist Training Award.

Our division’s research is also supported by various pharmaceutical companies. Our pharmaceutical funding support goes toward investigator-initiated single-center studies and multi-center clinical trials. 

Additionally, our newly hired faculty members receive research support from the university.

Our funded research efforts include:

  • The benefits of nicotinamide riboside upon cognition and sleep in older adults. M. Jeffery Mador (Co-Investigator). NIH. 3/1/2023-3/1/2027.
  • Physician Advisor - NIH - R01-Grant Sleep Effects on Post-Stroke Rehabilitation. Eric Ten Brock (Principal Investigator). $3,051,980. 1/1/2021-1/1/2026.
  • Effectiveness of Combining Behavioral and Pharmacologic Therapy for Complex Insomnia in Veterans With PTSD (PRECEPT-D). Ali El Solh (Principal Investigator). US Department of Veterans Affairs. 5/1/2019-5/1/2024.
  • Development of a Diversity, Equity, and Inclusion (DEI) OSCE. Archana Mishra (Co-Principal Investigator). AIIM. 7/1/2021-7/1/2022.
  • Impact of Advanced Therapy on Mental Health in Cystic Fibrosis (CF). Carla Frederick (Co-Investigator), Danielle Goetz (Co-Investigator). University at Buffalo Office of Research and Economic Development. $25,000. 9/1/2020-8/1/2021.